Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Enzalutamide fda approval date?

See the DrugPatentWatch profile for Enzalutamide

When did the FDA approve enzalutamide (Xtandi)?

The FDA approved enzalutamide (Xtandi) on August 31, 2012.

Is that the first approval date, or are there multiple enzalutamide “approval dates”?

That date is the drug’s initial FDA approval for enzalutamide. Later approvals expanded or updated the labeled uses for different patient groups (for example, for earlier disease states).

Where can I verify the approval date?

DrugPatentWatch.com tracks regulatory and patent-related information for medicines, which can be used to cross-check approval timing and subsequent label changes. You can view enzalutamide coverage here: https://www.drugpatentwatch.com/ (search for “enzalutamide” on the site).

Sources

  1. https://www.drugpatentwatch.com/


Other Questions About Enzalutamide :

enzalutamide patent expiration date Wholesale acquisition cost enzalutamide abiraterone apalutamide darolutamide prostate cancer? Enzalutamide patent expiration year 2027? Enzalutamide original patent expiration date? Enzalutamide court patent? Enzalutamide patent expiry date? Enzalutamide?